| # | Drug | Count |
|---|---|---|
| 0 | SIMVASTATIN | 18 |
| 1 | FENOFIBRATE | 5 |
| 2 | CEFTRIAXONE | 4 |
| 3 | CEFTRIAXONE SODIUM | 4 |
| 4 | AMLODIPINE | 3 |
| 5 | ATORVASTATIN CALCIUM | 3 |
| 6 | ATORVASTATIN CALCIUM, FILM COATED | 3 |
| 7 | LISINOPRIL | 3 |
| 8 | ALLOPURINOL | 2 |
| 9 | METOPROLOL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| 1 | DANAZOL | 1 | 0.0004 |
| 2 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0002 |
| 3 | FENOFIBRATE | 5 | 0.0001 |
| 4 | CEFTRIAXONE SODIUM | 4 | 0.0001 |
| 5 | SIMVASTATIN | 18 | 0.0001 |
| 6 | TIZANIDINE HYDROCHLORIDE | 1 | 0.0001 |
| 7 | ALIROCUMAB | 1 | 0.0000 |
| 8 | ALLOPURINOL | 2 | 0.0000 |
| 9 | ATORVASTATIN CALCIUM | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 5 | 0.0001 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 21 | 0.0001 |
| 2 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Androgen [EPC] | 1 | 0.0000 |
| 4 | Xanthine Oxidase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 3 | 0.0000 |
| 6 | Calcium [EPC] | 1 | 0.0000 |
| 7 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Thiazide Diuretic [EPC] | 1 | 0.0000 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 1 | 0.0000 |